infectious-diseases-2017-posters-accepted-abstracts

Page 106

conferenceseries

.com

Volume 5, Issue 3 (Suppl)

J Infect Dis Ther, an open access journal

ISSN:2332-0877

Infectious Diseases 2017

August 21-23, 2017

Annual Congress on

Infectious Diseases

August 21-23, 2017 San Francisco, USA

Lowprevalence of hepatitis B andCamong tuberculosis patients inDuhok Province, Kurdistan:AreHBsAg

and anti-HCV prerequisite screening parameters in tuberculosis control program?

Muayad A Merza, Safer M Haji, Abid Mohialdeen Hasan Alsharafani

and

Shivan U Muhammed

University of Duhok, Kurdistan Region, Iraq

Objective/Background:

Viral hepatitis, particularly hepatitis B virus (HBV) and hepatitis C virus (HCV), infections and

tuberculosis (TB) are a global public health concern. Co-infection with HBV or HCV among TB patients may potentiate the

risk of hepatotoxicity induced by anti-TB drugs. Hence, the aim of this study was to identify the prevalence of HBV and HCV

among TB patients included in the Duhok National Tuberculosis Program (NTP).

Methods:

The Duhok NTP Center is a specialized institution in Duhok City, Iraq, concerned with management and follow-

up of TB patients. A cross-sectional study was conducted at the center between June 2015 and May 2016. All documented TB

patients were analyzed on the basis of sociodemographic and other characteristics. Thereafter, all patients underwent screening

for hepatitis B surface antigen (HBsAg), anti-HCV, and anti-HIV using enzyme-linked immunosorbent assay (ELISA). The

results obtained were analyzed by entering the data in binary format into a Microsoft Excel spreadsheet. A p value of <.05 was

considered to be statistically significant.

Results:

Two-hundred fourteen (214) documented TB patients were recruited in this study, with 127 (59.3%) males and 87

(40.7%) females. The mean age of the patients was 40.34 years (±20.29). Of the total number of patients, 4 cases (1.8%) were

HBsAg-positive and one case (0.9%) was positive for anti-HCV. The variables significantly associated with HBV were history

of surgical dental procedure [odds ratio (OR), 0.04; 95% confidence interval (CI), _0.01 to 0.04; p=.03], and nationality (OR,

13.67; 95% CI, 0.46–210.85; p=.007).

Conclusion:

The prevalence of HBV and HCV co-infection among TB patients in this study was low. This may be explained

by the low rate of blood transfusion among the patients, and the very low prevalence of HIV.

J Infect Dis Ther 2017, 5:3 (Suppl)

DOI: 10.4172/2332-0877-C1-027